Items tagged with Scientific research

CAfGEN receives $3 million grant to study progression of TB and HIV (post with simple image)

The Consortium for African Genomics Network (CAfGEN), made up of University of Botswana, Makerere University, Baylor College of Medicine, Baylor Uganda Children’s Foundation and the Botswana-Baylor Children’s Clinical Centre of Excellence, has been awarded a $3.0 million three-year grant from the National Institutes of Health of the United States of America to study the genetic factors that affect the progression of TB and HIV in sub-Saharan Africa.

Novel vaccine trial design aims to answer key TB questions (post with simple image)

Prevention of infection study underway in South Africa.

CROI 2014: New drugs, novel combos top tuberculosis news at conference (post with simple image)

With increased TB activism and research into new treatments, preventive therapies, and diagnostics, the space devoted to TB at CROI has increased substantially.

Targeting a chink in TB bacteria’s armour (post with simple image)

A novel approach adopted by a team of researchers based in Bangalore has opened a window of opportunities to design new antimicrobials that could potentially be used to kill the tuberculosis-causing bacteria.

Novartis provides drug candidate compounds to TB Alliance (post with simple image)

Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis.

New vaccine shows promise as stronger weapon against both tuberculosis and leprosy (post with simple image)

UCLA-led research finds that a variant of an existing vaccine offers stronger protection against both diseases

PA-824 has a new generic name: pretomanid (post with simple image)

Pretomanid is a component of two new TB drug regimens being tested by TB Alliance for their ability to transform TB therapy, as well as future planned trials.

CRAG: A Protocol Review Companion for Activists (post with simple image)

The document is designed to facilitate community reviews of clinical trials protocols and to ensure community participation in protocol development.

Zombie bacteria in tuberculosis (post with simple image)

“Living-dead” bacteria exist in limbo: biologically active but not proliferating. Buried in this zombie state, disease-causing bacteria could come back from the dead to re-infect patients. Researchers at EPFL have produced the first evidence of this strange phenomenon in tuberculosis, suggesting new avenues for treatment.

Phase 2a published results show the potential of a new TB regimen with novel drugs bedaquiline and pretomanid (PA-824) (post with simple image)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial

Page 41 of 44 · Total posts: 0

←First 40 41 42 Last→